Empagliflozin

Dr. McPhee: This is not quite the best option in this case. Empagliflozin can an excellent drug, particularly for patients with certain co-morbidities, such as heart failure, chronic kidney disease, and established or high atherosclerotic cardiovascular (ASCVD) risk. It can also help when weight loss is a goal. There is no compelling cardiorenal indication to start it ahead of another drug that is more cost-effective and could also provide benefits in preventing complications and reducing weight.

Please go back and reconsider.

  • On the ward [undo]
  • Root Node [undo]
  • surfactant – diuretics – split bili and other tests [undo]
  • Ορισμός 2 [undo]
  • στεροειδή - διουρητικά - χολερυθρίνη και συζήτηση [undo]
  • In 1 year [undo]
  • Definition 2 [undo]
  • RESTRICȚIA DIGESTIEI ADN-ULUI PRIN ENDONUCLEAZE [undo]
  • Δεν κάνει τίποτα μετά τον τραυματισμό [undo]
  • Τα παρατάει [undo]
  • A, B, D [undo]
  • Furosemide (loop diuretic) [undo]
  • Pipetas [undo]
  • Empagliflozin [undo]

Map: Michael Green_GEMD_1 (1115)
Node: 21088
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway